Patent ID: 9700606
Date: 2017-07-11
CPC Classifications: A61K,A61P,C07K,G01N

Claim:
1. An isolated or purified cis complex comprising herpes virus entry mediator (HVEM) polypeptide binding to B- and T-lymphocyte attenuator (BTLA) polypeptide, wherein said HVEM polypeptide and said BTLA polypeptide in said cis complex are both human, or wherein said HVEM polypeptide and said BTLA polypeptide in said cis complex are both mouse, and wherein said cis complex does not detectably bind to a soluble HVEM polypeptide or a soluble BTLA polypeptide, or does not detectably bind to an HVEM polypeptide or a BTLA polypeptide to form a trans complex.